Nagasaki University

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Junshi Allies With Rxilient On JV

The California Institute of Regenerative Medicine (CIRM), which uses $3bn worth of state bond revenue to provide grants and loans for the development of stem cell therapies, approved a $6.2m funding a

Pharmaceuticals Alnara Pharmaceuticals Inc. Cystic Fibrosis Foundation Cystic Fibrosis Foundation Therapeutics Inc. Alnara secures exclusive global license to CFFT's liprotamase March — Alnara Pharma

In Vitro Diagnostics Acquisitions / In Vitro Diagnostics Abbott Laboratories Inc. Abbott Molecular Inc. Health Discovery Corp. Diagnostics company Health Discovery Corp. has granted Abbott Molec